Levofloxacin + Ornidazole in pharma franchise in Rajasthan

Levofloxacin + Ornidazole in PCD pharma franchise in Hyderabad

Levofloxacin + Ornidazole in top pharma company in Vijayawada

Levofloxacin + Ornidazole in pcd pharma supplier in Coimbatore

Levofloxacin + Ornidazole in phama franchise company in India
Levofloxacin + Ornidazole in phama distributor in Gwalior

Home/Products /levofloxacin-250mg-ornidazole-500mg-tablet

Lexoziff OZ Tablet

Composition : Levofloxacin (250mg) + Ornidazole (500mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹168/-

Lexoziff OZ Tablet is a potent combination of two active ingredients: Levofloxacin, a broad-spectrum antibiotic, and Ornidazole, an effective antiprotozoal agent. This combination is designed to treat various bacterial and parasitic infections, providing a comprehensive solution for patients suffering from infections caused by both bacteria and protozoa.

Levofloxacin, a fluoroquinolone antibiotic, works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial replication. This action helps prevent the growth and spread of a wide range of bacterial infections, including respiratory, urinary tract, and skin infections. Ornidazole, on the other hand, is effective against protozoal infections and anaerobic bacteria, targeting the DNA of the pathogens and preventing their reproduction, thus eliminating the infection.

This combination therapy is particularly useful in treating infections where both bacterial and protozoal pathogens are involved, such as in cases of gynecological infections, dental infections, and intestinal infections caused by mixed bacterial and protozoal flora. It provides a convenient treatment option that simplifies the management of complex infections.

Read More

About the Product

Lexoziff OZ Tablet is a potent combination of two active ingredients: Levofloxacin, a broad-spectrum antibiotic, and Ornidazole, an effective antiprotozoal agent. This combination is designed to treat various bacterial and parasitic infections, providing a comprehensive solution for patients suffering from infections caused by both bacteria and protozoa.

Levofloxacin, a fluoroquinolone antibiotic, works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial replication. This action helps prevent the growth and spread of a wide range of bacterial infections, including respiratory, urinary tract, and skin infections. Ornidazole, on the other hand, is effective against protozoal infections and anaerobic bacteria, targeting the DNA of the pathogens and preventing their reproduction, thus eliminating the infection.

This combination therapy is particularly useful in treating infections where both bacterial and protozoal pathogens are involved, such as in cases of gynecological infections, dental infections, and intestinal infections caused by mixed bacterial and protozoal flora. It provides a convenient treatment option that simplifies the management of complex infections.

Common side effects include nausea, vomiting, diarrhea, headache, dizziness, and skin rashes. Severe allergic reactions are rare.

Lexoziff OZ Tablet is indicated for the treatment of bacterial and protozoal infections, including gynecological infections, intestinal infections, and respiratory infections.

Do not use if allergic to Levofloxacin, Ornidazole, or any tablet components. Consult a doctor before use if pregnant, breastfeeding, or suffering from liver or kidney disease.

Store in a cool, dry place below 30°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation